SIRS may induce an HS factor-1 (HSF-1) competitive inhibition of nuclear factor-κB (NF-κB) nuclear binding and prevent NF-κB from being released from its complex with IκBα, seriously affecting innate immunity [13]. This evidence concerns the gene NFKB1 and systemic inflammatory response syndrome.